Issue link: http://osercommunicationsgroup.uberflip.com/i/858127
Chain Drugstore Daily 2 3 Sunday, August 20, 2017 UNIWEB OFFERS FLEX COUNTER MODULAR COMPONENTS Uniweb's passion to create thrives in its ability to respond to its customer's needs. This level of commitment streamlines into developing innovative and seamless mer- chandising systems to solve customer chal- lenges. For more than 46 years, Uniweb has continually anticipated and responded to changing business conditions. The com- pany's pledge is to create the most cost- efficient user-friendly storage systems. Adaptable, portable and flexible, Uniweb Modular FLEX Components deliver endless possibilities. Uniweb FLEX Modular Counter Systems provide an integrated and accommodating clutter- free functional working environment engi- neered and tailored to meet your specific needs. An array of storage above and below the work area will keep your team organized and supplies conveniently with- in reach, allowing for maximum workflow. The versatile free standing modular components include: UL-Listed Modular Wiring; blank conduit and communica- tion boxes allow for easy communication and data transmission; Uniweb Modular counter units and equipment easily tie in to existing power and plumbing sources; laminate tops and privacy screens matched to your color scheme; exterior preferences can include laminate or Uniweb panels for increased display pos- sibilities; millwork designed to your requirements; quick and simple installa- tion; interchangeable under-counter and fixtures and accessories can be easily reconfigured by store per- sonnel; and accessories … infinite options! The ultimate beauty of Uniweb's craftsmanship: as your needs change, so can your modular space. Whether you need more space or need to change your operation's layout, you are not locked into your original design. These dynamic counters, cabinets, shelv- ing and accessories provide unlimited transitions, giving you the freedom to design and equip your space for unsur- passed utility and appearance at an affordable price. Many design possibilities are avail- able: custom metal finishes, trim, décor panels, laminates, wood and wood veneers, decorative glass, tile, awnings, special lighting, signage and much more! Uniweb works with your staff and archi- tects to design the room's exterior and/or interior to meet your company's specific aesthetic require- ments, including surface options, materials, custom colors and finishes to coordinate with your surrounding store interiors. Together, they help to create a welcoming ambiance for customers and staff to enjoy. Give Uniweb your challenges today. The company would be proud to show you current satisfied customer installa- tions, take you on a tour of the new, state- of-the-industry 180,000 square foot man- ufacturing facility and meet with your team to start discussions on your next remodel project. Visit Uniweb at booth #2631. For more information, call 800.486.4932 or go to www.uniwebinc.com. ALENDRONATE SODIUM ORAL SOLUTION NDC# 51224-301-10 Why choose Alendronate Oral Solution? It's the only retail centered, non- injectable generic alternative to the tablet. It's the only Alendronate Oral Solution on the market. It's the only generic Alendronate that's not a tablet. It's cov- ered by Medicaid, most Medicare and most private insurance policies. It is stocked and available at your preferred wholesaler or available for direct ship- ment. The minimum order quantity has been reduced to one unit for direct orders. In 2013, TAGI Pharma, Inc., announced the launch of its Alendronate Sodium Oral Solution, 70mg/75mL, once weekly, bone resorption suppression agent in the United States and its territo- ries, possessions and protectorates. This FDA approved oral solution is the sole source generic alternative to Merck & Co., Inc.'s FOSAMAX ® (Alendronate Sodium) Oral Solution and is indicated for the treatment of osteoporosis in post- menopausal women. In postmenopausal women, Alendronate increases bone mass and reduces the incidence of fractures, including those of the hip and spine (ver- tebral compression fractures), and as treatment to increase bone mass in men with osteoporosis. Contraindications: abnormalities of the esophagus which delay esophageal emptying such as stric- ture or achalasia; inability to stand or sit upright for at least 30 minutes; do not administer Alendronate Sodium Oral Solution to patients at increased risk of aspiration; hypocalcemia; hypersensitivity to any compo- nent of this product; hypersensi- tivity reactions including urticaria and angioedema have been reported. Thomas Anderson, Executive President, said "Alendronate Oral Solution represents a key step for- ward in the implementation of TAGI Pharma's business plan to bring differen- tiated products to the marketplace." Kenny Harrington, Vice President of Sales and Marketing, said, "Alendronate Sodium Oral Solution addresses unmet needs in the market for a liquid Alendronate product, and complements the TAGI strategy to provide unique products to underserved customers." "TAGI Pharma, Inc. was established to target the generic retail market," said Anderson, "and our product selection for TAGI Pharma is focused on higher barri- ers to entry and lim- ited competition where there are mar- ket expansion oppor- tunities in the retail market, as well as the non-retail sector currently being serviced by Precision Dose, our parent company. Keys to our success have been a thorough under- standing of the markets we compete in and identification of profitable product opportunities that provide an added value to our customers, with a foundation ® always grounded in product quality and high service level performance." Visit TAGI Pharma at booth #4715. Visit www.tagipharma.com to view Alendronate Sodium Oral Solution full prescribing information, which includes indications for use and additional impor- tant safety information. NATROL INTRODUCES ADVANCED LINE OF SUPPLEMENTS Natrol ® , the No. 1 brand of melatonin and a leading vitamin, mineral and supple- ment brand for 36 years, recently launched its Natrol Advanced line, a pre- mium line of supplements featuring supe- rior formulations designed to address multiple benefits with increased efficacy. "In consumer research, we consis- tently heard consumers sharing wellness concerns that require a more complex approach," says Thomas Hart, Marketing Director at Natrol. "Finding the right solution can be a challenge for con- sumers in a confusing supplement cate- gory filled with many single ingredients and weak formulations, the benefits of which are often difficult to understand. For example, they might not just have difficulty falling asleep, but this is often compounded by an inability to calm the mind so they can relax and fall asleep. Natrol Advanced Sleep was developed to address issues like this in one highly effective product." The Natrol Advanced line consists of three products: Advanced Sleep – Melatonin+5-HTP: a triple-action sleep formula developed to help overcome the three most common sleep concerns – a racing mind, difficulty falling asleep and difficulty sleeping through the night. Formulated in a unique, bi-layer tablet, it releases an initial burst of 5- HTP and melatonin to help you calm the mind and fall asleep faster, followed by a con- trolled-release of melatonin to help you stay asleep through the night. Advanced Beauty – Skin, Hair & Nails: a superior formulation in the growing hair, skin and nails segment featuring clinical strength lutein that has been paired with collagen and hyaluronic acid to help improve skin elasticity and hydra- tion, biotin to promote lustrous hair and stronger nails, and alpha lipoic acid and Vitamins A, C and E to protect against free radicals and oxidative damage. Advanced Joint Mobility – Extra Strength Turmeric: proven support for a nor- mal, healthy inflamma- tion response that leads to improved joint mobili- ty formulated with a con- centrated grade of turmeric, with higher levels of curcumi- noids clinically proven to have 46 times greater absorption than standard grade curcumin. "The new Advanced premium supple- ments line tested well with consumers, and we are encouraged to see that now being borne out in the market," Hart said. Natrol plans to grow the line into new segments as early as next year. Visit Natrol at booth #3345. For more information, go to www.natrol.com. EMERGENT BIOSOLUTIONS MODIFIES BOTULISM ANTITOXIN AGREEMENT Emergent BioSolutions Inc. has signed a modification to its contract with the Biomedical Advanced Research and Development Authority (BARDA) to manufacture and store bulk drug sub- stance for its botulism antitoxin, BAT ® [Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G) - (Equine)], valued at approximately $53 million with a five- year period of performance. This modi- fication to the contract will enable future filling and deliveries of final drug product to the Strategic National Stockpile (SNS). BAT is indicated for the treatment of symptomatic botulism following documented or suspected exposure to botulinum neurotoxin serotypes A, B, C, D, E, F, or G in adults and pediatric patients. Emergent has been supplying BAT to the SNS under contract HHSO100200600017C, which was signed in 2006 with BARDA, within the Office of the Assistant Secretary for Preparedness and Response, in the U.S. Department of Health and Human Services. BAT is the only botulism antitoxin licensed by the U.S. Food and Drug Administration and distrib- uted from the Centers for Disease Control and Prevention for treating naturally occurring, non-infant botu- lism, and for administration under emergency conditions.